-
61por Volpedo, Greta, Pacheco-Fernandez, Thalia, Holcomb, Erin A., Cipriano, Natalie, Cox, Blake, Satoskar, Abhay R.“…Leishmaniasis is a neglected tropical disease that affects 12 million people worldwide. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
62Publicado 1990Materias: “…Leishmaniasis Prevención.…”
Libro -
63Publicado 2012Materias: “…Leishmaniasis Diagnóstico.…”
Libro -
64
-
65
-
66por Morgado, Fernanda N., Conceição-Silva, Fátima, Pimentel, Maria Inês F., Porrozzi, RenatoEnlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
67
-
68por Martín-Sánchez, Joaquina, Morales-Yuste, Manuel, Acedo-Sánchez, Carmen, Barón, Sergio, Díaz, Victoriano, Morillas-Márquez, Francisco“…To examine prevalence changes and risk factors for canine leishmaniasis, we conducted a cross-sectional seroprevalence study and a survey during April–June 2006. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
69por Maltezou, Helena C.“…Visceral leishmaniasis remains a public health problem worldwide. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
70
-
71por Nawaratna, Sujeevi S.K., Weilgama, Danister J., Wijekoon, Chandana J., Dissanayake, Manel, Rajapaksha, Kosala“…Cutaneous leishmaniasis (CL) is an emerging disease in Sri Lanka. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
72por Clem, Angela“…There are many challenges facing the successful control and eradication of cutaneous and visceral leishmaniasis. Leishmaniasis is still endemic in many poverty stricken and war torn areas. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
73por Claborn, David M“…Vector control remains a key component of many anti-leishmaniasis programs and probably will remain so until an effective vaccine becomes available. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
74por Palumbo, Emilio“…The evidence for optimal treatment of mucocutaneous leishmaniasis is patchy. Although the cutaneous form of the disease is often self-limiting, it does result in significant scarring and can spread to more invasive, mucocutaneous disease. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
75“…Improved understanding of the immunology involved in co-infections may help in designing prophylactic and therapeutic strategies against Leishmaniasis.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
76“…First-line drug treatment was recorded in 573 immunocompetent patients with visceral leishmaniasis in Italy. In the past 12 years, the proportion of antimonial treatments decreased from 100% to 2.8%, while the proportion of amphotericin B treatments increased from 0% to 97.2%. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
77“…Persistence or resolution of leishmaniasis is governed by host immune response. Co-stimulation is an important secondary signal that governs the extent, strength and direction of the immune response that follows. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
78
-
79“…Two patients with mini-volcano type of skin lesions which showed histopathologic features of cutaneous leishmaniasis (CL) have been described. It was localised and linear in one case while widespread in the other. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
80por Reithinger, Richard, Aadil, Khoksar, Kolaczinski, Jan, Mohsen, Mohammad, Hami, SamadEnlace del recurso
Publicado 2005
Enlace del recurso
Enlace del recurso
Online Artículo Texto